Podcast

One Survivor's 'Twist' on Cancer

Author(s):

In this episode of the “CURE Talks Cancer” podcast, Twist Out Cancer founder Jenna Benn Shersher shares on her journey with grey zone lymphoma and how her organization helps pair individuals to use art as an outlet to cope through cancer.

After being diagnosed with grey zone lymphoma — a very rare type of cancer – Jenna Benn Shersher was isolated due to her compromised immune system. However, it didn’t take long for thousands to join her on her journey when a video of her doing the twist in the ICU went viral.

Following her experience, she founded Twist Out Cancer, an organization that provides psychosocial support to individuals touched by cancer through creative arts programming. It pairs those touched by cancer with an artist, who creates a unique piece of artwork that reflects on their individual journey with cancer, through its Brushes with Cancer program.

“It's all about storytelling and empowering people with their story so that they feel comfortable moving forward and also educating the public in the process,” Shersher said.

In this week’s episode, we spoke with her about her journey with cancer, as well as why organizations like Twist Out Cancer can help those affected by a cancer diagnosis — whether it be a patient, survivor or loved one.

For more information, visit twistoutcancer.org.

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with a brown hair tied into a bun.
Related Content